Cleft Palate Treatment: Tissue-Engineered Oral Mucosa Substitute

We are testing a new tissue-engineered substitute for patients with cleft palate to see if it is safe and effective for healing and improving quality of life. The study will compare outcomes with standard treatments.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Ex Vivo Expanded Autologous Human Corneal Epithelial Cells Containing Stem Cells
Patient's own corneal cells grown outside the body that contain stem cells are used to restore and repair a damaged corneal surface, improving vision.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Autologous Oral Mucosa-Derived Adult Keratinocytes
Autologous Oral Mucosa-Derived Adult Fibroblasts

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitario Virgen De Las Nieves
Cirugía Pediatrica
Granada, Spain
Sponsor: Fundacion Publica Para La Investigacion Biosanitaria De Andalucia Oriental Alejandro Otero
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.